open access

Vol 23, No 3 (2017)
Original papers
Published online: 2017-09-28
Get Citation

Prognosis of morbidity on type 2 diabetes according to the FINDRISC questionnaire — preliminary study

Zanna Fiodorenko-Dumas, Magdalena Starzyk, Malgorzata Paprocka-Borowicz, Rafal Malecki, Maciej Rabczynski, Rajmund Adamiec
DOI: 10.5603/AA.2017.0009
·
Acta Angiologica 2017;23(3):124-129.

open access

Vol 23, No 3 (2017)
Original papers
Published online: 2017-09-28

Abstract

Introduction. Diabetes is not only an issue related to secretory organs or complications permanently attached to any ongoing disease process, but it is also an issue of public health as it is one of the four top priority non-contagious diseases the entire world is fighting against. The aim of this research was to assess the risk of possible diabetes incidence amongst a group of test subjects which may occur in the next decade. The study was based on a FINDRISC questionnaire.

Material and methods. The research group were comprised of 100 responders at the ages of 18 to 88, including 70 female and 30 male subjects. The mean age of the men was 47.6 ± 19.98 years, while for the women it was 53.61 ± 18.31 years.

Results. The results obtained in the questionnaire showed that the risk of diabetes incidence increased in subjects who turned 55 years of age in comparison to the younger responders. The risk of developing diabetes increased with the increase of BMI at the correlation coefficient 0.657 and p < 0.001.

Conclusions. Genetic affinity was determined to be an irrelevant variable in the risk of developing diabetes. Both BMI and the age were strong factors determining the future risk of diabetes incidence.

Abstract

Introduction. Diabetes is not only an issue related to secretory organs or complications permanently attached to any ongoing disease process, but it is also an issue of public health as it is one of the four top priority non-contagious diseases the entire world is fighting against. The aim of this research was to assess the risk of possible diabetes incidence amongst a group of test subjects which may occur in the next decade. The study was based on a FINDRISC questionnaire.

Material and methods. The research group were comprised of 100 responders at the ages of 18 to 88, including 70 female and 30 male subjects. The mean age of the men was 47.6 ± 19.98 years, while for the women it was 53.61 ± 18.31 years.

Results. The results obtained in the questionnaire showed that the risk of diabetes incidence increased in subjects who turned 55 years of age in comparison to the younger responders. The risk of developing diabetes increased with the increase of BMI at the correlation coefficient 0.657 and p < 0.001.

Conclusions. Genetic affinity was determined to be an irrelevant variable in the risk of developing diabetes. Both BMI and the age were strong factors determining the future risk of diabetes incidence.

Get Citation

Keywords

diabetes, FINDRISC questionnaire, obesity, metabolic disease

About this article
Title

Prognosis of morbidity on type 2 diabetes according to the FINDRISC questionnaire — preliminary study

Journal

Acta Angiologica

Issue

Vol 23, No 3 (2017)

Pages

124-129

Published online

2017-09-28

DOI

10.5603/AA.2017.0009

Bibliographic record

Acta Angiologica 2017;23(3):124-129.

Keywords

diabetes
FINDRISC questionnaire
obesity
metabolic disease

Authors

Zanna Fiodorenko-Dumas
Magdalena Starzyk
Malgorzata Paprocka-Borowicz
Rafal Malecki
Maciej Rabczynski
Rajmund Adamiec

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl